Abergel A;Rotily M;Branchoux S;.Chronic hepatitis C:Burden of disease and cost associated with hospitalisations in France in 2012(The HEPC-LONE study).Clinics and Research in Hepa-tology and Gastroenterology.2016.340-348Abergel A,Rotily M,Branchoux S,et al.Chronic hepatitis C:Burden of ...
Untreated, between 15% and 42% of infected persons resolve infection2-4; about half of those chronically infected develop progressive liver disease, which may include cirrhosis and hepatocellular carcinoma.5,6 Approximately 18 000 people died in 2016 because of HCV infection.5-7 Historically, ...
Of the 280 AK-HepC cohort deaths, 251 (89.6%) had at least one ICD code listed on their death certificate. This proportion was significantly lower compared to the AN population and non-AN populations where over 99% of deaths had at least one ICD death code (99.5% and 99.6%;P < ...
HCV-infected subjects with the following pre-existing or co-existing comorbidities were excluded: diabetes (ICD-9-CM code 250), hypertension (ICD-9-CM codes 401–405), hyperlipidemia (ICD-9-CM codes 272–272.4), coronary heart disease (ICD-9-CM codes 410–414), and liver cirrhosis (ICD-...
Introduction Chronic hepatitis B can lead to cirrhosis and hepatocellular carcinoma, resulting in premature death. In addition to increased mortality from liver-related causes, chronic hepatitis B has been associated with premature mortality and elevated mortality rates from all causes.1-4 Elevated mortal...
unspecified 564.1 Irritable bowel syndrome 569.3 Hemorrhage of anus and rectum 571.5 Cirrhosis Liver w/o mention of alcohol 571.8 Other chronic liver disease 573.3 Hepatitis, unspecified 578.1 Blood in Stool 579.0 Celiac disease 579.3 Postsurgical malabsorption, not elsewhere classified 585.3 Chronic kidney...
HBV vaccine indication established in 68.5% of patients was greater among women and hepatitis C virus-negative patients. No differences were observed in age or cause of cirrhosis. HAV vaccination indicated in 6.7% of patients (IgG anti-HVA-negative) was greater among patients with negative HBV ...
Late presentation with viral hepatitis was defined as patients who were not known to be infected previously but presented with symptoms of cirrhosis and/or HCC for medical care [10]. The clinical implications of late presentation of hepatitis B at the population level are largely unexplored. In ...
HBV causes acute and chronic hepatitis B; chronic HBV infection puts more than 250 million virus carriers at a greatly increased risk to develop terminal liver disease, i.e., liver fibrosis, cirrhosis and hepatocellular carcinoma (HCC) [1]. While an effective prophylact...
There was development of (a) HCC in 10 patients (all with cirrhosis): SIR (95% CI) 41 (20–75); (b) lympho-proliferative cancer in 6 patients: SIR 2.94 (1.08–6.4: (c) ≥1 NMSC in 15 patients (2000–13): SIR 2.95 (1.65–4.87). SIR for all other extra-hepatic cancers ...